22290004: Antigen of Hepatitis B virus surface protein (substance)

SNOMED CT Concept\Substance\Biological substance\Immunologic substance\Antigen\Microbial antigen\Virus antigen\Antigen of Hepatitis B virus (substance)\Hepatitis B surface antigen

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Hepatitis B surface antigen	Is a	Antigen of Hepatitis B virus (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Hepatitis B virus subtype ayr surface antigen	Is a	True	Hepatitis B surface antigen	Inferred relationship	Some
Hepatitis B virus subtype adr surface antigen	Is a	True	Hepatitis B surface antigen	Inferred relationship	Some
Hepatitis B virus subtype adw surface antigen	Is a	True	Hepatitis B surface antigen	Inferred relationship	Some
Hepatitis B virus subtype ayw surface antigen	Is a	True	Hepatitis B surface antigen	Inferred relationship	Some
Hepatitis B surface antigen measurement	Has measured component (attribute)	False	Hepatitis B surface antigen	Inferred relationship	Some
Hepatitis B virus surface antigen antibody	Direct substance	False	Hepatitis B surface antigen	Inferred relationship	Some
Hepatitis B surface antigen measurement	Component	False	Hepatitis B surface antigen	Inferred relationship	Some
Measurement of Hepatitis B surface antigen and Hepatitis C antibody (procedure)	Component	False	Hepatitis B surface antigen	Inferred relationship	Some
Hepatitis B virus recombinant surface antigen	Is a	True	Hepatitis B surface antigen	Inferred relationship	Some
Hepatitis B surface antigen measurement	Component	True	Hepatitis B surface antigen	Inferred relationship	Some	1
Measurement of Hepatitis B surface antigen and Hepatitis C antibody (procedure)	Component	True	Hepatitis B surface antigen	Inferred relationship	Some	1
Product containing precisely hepatitis B surface antigen 20 microgram/1 milliliter conventional release suspension for injection syringe	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hepatitis B surface antigen	Inferred relationship	Some	1
Product containing precisely hepatitis B surface antigen 20 microgram/1 milliliter conventional release suspension for injection syringe	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hepatitis B surface antigen	Inferred relationship	Some	1
Product containing precisely hepatitis B surface antigen 20 microgram/1 milliliter conventional release suspension for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hepatitis B surface antigen	Inferred relationship	Some	1
Product containing precisely hepatitis B surface antigen 20 microgram/1 milliliter conventional release suspension for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hepatitis B surface antigen	Inferred relationship	Some	1
Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hepatitis B surface antigen	Inferred relationship	Some	1
Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hepatitis B surface antigen	Inferred relationship	Some	1
Product containing surface antigen of Hepatitis B virus in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hepatitis B surface antigen	Inferred relationship	Some	1
Product containing surface antigen of Hepatitis B virus (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hepatitis B surface antigen	Inferred relationship	Some	1
Product containing only surface antigen of Hepatitis B virus (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hepatitis B surface antigen	Inferred relationship	Some	1
Product containing only surface antigen of Hepatitis B virus in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hepatitis B surface antigen	Inferred relationship	Some	1
Product containing precisely surface antigen of Hepatitis B virus 20 microgram/1 milliliter conventional release suspension for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hepatitis B surface antigen	Inferred relationship	Some	1
Product containing precisely surface antigen of Hepatitis B virus 20 microgram/1 milliliter conventional release suspension for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hepatitis B surface antigen	Inferred relationship	Some	1
Vaccine product containing only inactivated whole Hepatitis A and Hepatitis B surface antigens (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hepatitis B surface antigen	Inferred relationship	Some	2
Acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens only pediatric vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hepatitis B surface antigen	Inferred relationship	Some	2
Hepatitis B surface antigen only vaccine product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hepatitis B surface antigen	Inferred relationship	Some	1
Paediatric vaccine inactivated whole Hepatitis A and Hepatitis B surface antigens only vaccine product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hepatitis B surface antigen	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
37421011	Australian antigen	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
196183010	Hepatitis B surface antigen	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
3780436010	Hepatitis B virus surface Ag	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
3901325014	Antigen of Hepatitis B virus surface protein	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3901326010	Antigen of Hepatitis B virus surface protein (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
294431000077116	antigène de surface de l'hépatite B	fr	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module